Taking a beating. Healthcare execs see stock holdings, company portfolios nosedive.
The pounding that healthcare companies have taken on Wall Street is getting personal for their CEOs, whose holdings at their respective companies are down more than $180 million in value this year. "The key driver of incentives is stock holding. That's where the action is," says Wayne Guay, left, of the Wharton School. Boards may want to consider increasing their CEOs' relative weighting to equity compensation, he says.